(a) Multivariate logistic regression analysis of AKI development | ||||
---|---|---|---|---|
95% CI for odds ratio | ||||
Odds ratio | P -value | Lower | Upper | |
Age >60 years | 3.107 | 12.117 | ||
TBSA burned >50% | 8.628 | 0.000* | 5.036 | 14.783 |
Sex, female | 4.199 | 0.000* | 1.940 | 9.086 |
Inhalation injury present | 3.129 | 0.000* | 1.734 | 5.647 |
Serum creatinine >1.1 mg/dL | 74.930 | 0.000* | 7.926 | 708.331 |
Serum cystatin C >1.1 mg/L | 0.150 | 0.038* | 0.025 | 0.902 |
Plasma NGAL >153 ng/mL | 1.924 | 0.016* | 1.128 | 3.282 |
Urine NGAL >131 ng/mL | 2.568 | 0.009* | 1.263 | 5.220 |
(b) Multivariate logistic regression analysis of mortality | ||||
95% CI for odds ratio | ||||
Odds ratio | P -value | Lower | Upper | |
Age >60 years | 23.322 | 0.000* | 9.885 | 55.023 |
TBSA burned >50% | 25.821 | 0.000* | 12.037 | 55.389 |
Sex, female | 4.704 | 0.000* | 1.999 | 11.070 |
Inhalation injury present | 0.923 | 0.771 | 0.536 | 1.588 |
Serum creatinine >1.1 mg/dL | 0.976 | 0.947 | 0.480 | 1.986 |
Serum cystatin C >1.1 mg/L | 2.562 | 0.137 | 0.741 | 8.853 |
Plasma NGAL >153 ng/mL | 1.886 | 0.023* | 1.091 | 3.259 |
Urine NGAL >131 ng/mL | 7.854 | 0.000* | 3.949 | 15.622 |